OB-GYN association issues its own vaccine schedule for pregnancy, diverging from CDC guidance
The American College of Obstetricians and Gynecologists this week issued its own schedule of recommended vaccines for pregnancy. According to STAT News, the document diverges from recent CDC updates at multiple points.
The ACOG document revisits the timing and risk assessment of core pregnancy vaccines including the COVID-19 booster, RSV protection and influenza. The college said its recommendations rest on the most recent clinical evidence.
The CDC's recent guidance moves on several vaccines to a shared decision-making framework, which had introduced uncertainty among physicians. ACOG says clinicians need a clearer map for everyday clinical decisions.
ACOG officials told STAT News the divergence is not a political stance but a technical step to preserve the clinical standard of care. The college said it had received signals of rising vaccine deferral among pregnant patients.
The practical consequences play out in prenatal care. On one side, the federally recommended schedule; on the other, the clinical standard set by the professional college. The mismatch could complicate insurance reimbursement and state-level policy.
Public-health experts said the kind of public divergence between a specialty college and the CDC is unusual. The two normally reach alignment behind closed doors; an open split signals strain in the relationship between federal health administration and specialty bodies.
The ACOG document includes a clinical decision matrix for the trade-off between an RSV monoclonal antibody and the maternal RSV vaccine. That gives physicians who weigh either path to infant protection a standard reference.
On the COVID-19 booster, ACOG holds the view that pregnant patients may be vaccinated at any stage of pregnancy. Limitations introduced in the CDC's recent guidance had created the risk of insurance coverage gaps in some states.
The college said it would maintain an annual update and that vaccine decisions would be assessed on clinical evidence rather than on a federal-court footing. STAT News reported that federal officials had not yet issued a formal response.
Vesper covers health and medical research for information only; this article is not medical advice. Vaccine decisions should be made with a qualified clinician.
Read next
Is the rise of GLP-1s reshaping ideas of Black beauty?
The mainstreaming of GLP-1 obesity drugs is reigniting a conversation about cultural beauty standards. A long Guardian feature explores how settled ideas about body aesthetics in Black women's culture are entering a new test.
How ultra-processed foods may be stealing your focus, even if you eat healthy
A new study finds ultra-processed foods leave a measurable mark on attention and short-term memory even when the rest of the day's diet is healthy. The findings, summarised by Science Daily, tie nutrition science back into the debate over focus.
Extreme heat will double US hospitalisations by 2040, new study warns
A research team says that if the current climate trajectory holds, US heat-related hospitalisations will double by 2040. The study, summarised by the Guardian, finds health systems "woefully unprepared" for the load.
Top five-a-day foods a new study says your heart needs
Britain's five-a-day advice has been repeated, mostly unchanged, since the 1990s. A new study summarised by the BBC says the make-up of the five portions matters far more than long thought — and five specific foods stand out clearly for heart health.
Why some cancer treatments stop working: the resistance biology researchers are mapping
Researchers have identified a hidden cellular mechanism that allows tumour cells to shrug off the most advanced therapies. The study, summarised by Science Daily, points to a new way to predict and reverse drug resistance — one of oncology's hardest problems.
